In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bacchus Vascular Inc.

Division of Medtronic PLC
www.bacchus-vascular.com

Latest From Bacchus Vascular Inc.

The A-List: The Trend-Shaping Series A Financings Of 2011

The capital drought that hit life science companies the past three years worked its way upstream in 2011, as several venture firms said they wouldn’t either continue in the life sciences or raise new funds. But our annual tally of life science Series A rounds presents a surprising twist: Series A rounds are up, not in blockbuster numbers by any stretch, but the downward trend of the recession years has finally been reversed. Among the year's nearly 100 Series A rounds we found plenty of oncology and peripheral vascular disease start-ups, as well as big bets on rare disease, along with some considerable nods to emerging markets.

BioPharmaceutical Medical Device

Covidien Still Hungry For GI After Barrx Buy

Just as it did with VNUS, Covidien snapped up a smaller leader in a field where it had very little contact – esophageal cancer and its precursor Barrett’s esophagus – with the intent of building a larger presence. Covidien paid $325 million for Barrx Medical Inc., developer of a radiofrequency tool capable of eliminating Barrett’s, a condition in which damaged esophageal tissue presents an elevated risk of developing into esophageal cancer.

Medical Device North America

ISC 2011: Stroke Device Innovation and Investment

At this February's International Stroke Conference held in Los Angeles, the latest advances in cerebrovascular disease diagnosis, treatment, and prevention were highlighted, including cutting-edge endovascular therapies for use in acute ischemic stroke treatment and prevention, as well as new options for more deadly hemorrhagic stroke.
Medical Device

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover Covidien's acquisition of ev3, J&J's moves in the endovascular market, DePuy's launch of new products in hip revision, and FDA regulation of consumer genomics.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Mike Gandy, VP, Fin. & CFO
    Eric W Heil, VP, US Sales
    Bob McRae, VP, Research & Bus. Dev.
  • Contact Info
  • Bacchus Vascular Inc.
    Phone: (408) 980-8300
    3110 Coronado Dr.
    Santa Clara, CA 95054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register